Increased annexin A2 and decreased β-catenin in adenomyosis contribute to adenomyosis-associated dysmenorrhea.
Increased annexin A2 and decreased β-catenin expression in adenomyosis tissues correlate with the severity of adenomyosis-associated dysmenorrhea.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This study investigated the expression levels of annexin A2 and β-catenin in eutopic and ectopic endometrium from patients with adenomyosis compared to a control group with uterine myomas. Researchers utilized immunohistochemistry and enzyme-linked immunosorbent assays to measure protein concentrations and analyzed their correlation with the severity of dysmenorrhea using Pearson correlation coefficients. The results demonstrated that annexin A2 was significantly upregulated while β-catenin was downregulated in adenomyosis tissues, with higher annexin A2 and lower β-catenin levels positively and negatively correlating, respectively, with increased pain intensity. This paper is centrally about adenomyosis — specifically examining molecular markers associated with adenomyosis-associated dysmenorrhea.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
2,262 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cited by (2)
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-09-30T06:18:36.089610+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:20:25.745717+00:00